This inventor holds 161 USPTO granted patents and 84 published patent applications, plus 7 CIPO patents and 37 EPO patents, primarily in Gene Editing Technologies (CPC class C12N9-22). Top assignees: Harvard College, The Broad Institute, Inc., Scripps Research Institute. Active years: 2006-2026.
Inventors with similar research interests:
Location History:
- Lexington, MA (US) (2006 - 2024)
- Cambridge, MA (US) (2015 - 2024)
Company Filing History:
140 out of 3,069 
23 out of 480 
14 out of 1,204 
Years Active: 2006-2026
Areas of Expertise:
Title: The Innovative Mind of David R Liu: Transforming Nucleic Acid Editing
Introduction:
David R Liu, a distinguished inventor based in Lexington, MA, has made remarkable contributions to the field of targeted nucleic acid editing. With an impressive portfolio of 126 patents, David R Liu continues to push the boundaries of scientific innovation.
Latest Patents:
Among his latest patents is the creation of High Efficiency Base Editors comprising Gam, revolutionizing targeted editing of nucleic acids. These editors encompass fusion proteins with Gam protein, a napDNAbp, and a cytidine deaminase, providing novel methods for precise genome editing. Additionally, his Nuclease Profiling System offers strategies to determine nuclease target site preferences and specificity, enhancing the efficiency of site-specific endonucleases.
Career Highlights:
David R Liu has worked with prestigious organizations such as Harvard College and The Scripps Research Institute, where his groundbreaking research has garnered international recognition. His expertise in molecular biology and genome editing has positioned him as a trailblazer in the scientific community.
Collaborations:
Throughout his career, David R Liu has collaborated with notable colleagues such as David B Thompson and Peter G Schultz. These partnerships have led to the development of cutting-edge technologies and methodologies, shaping the future of genetic engineering and precision medicine.
Conclusion:
David R Liu's inventive spirit and unwavering dedication to advancing nucleic acid editing have established him as a visionary in the field of biotechnology. His prolific patent portfolio and groundbreaking research continue to inspire future generations of innovators.